Alembic Pharma shares jump 5% on final USFDA nod to Seizure treatment drug

October 3, 2024
Uncategorized

According to IQVIA data, the market size for Lamotrigine Extended-Release tablets in these strengths is estimated to be around $163 million for the 12 months ended June 2024.

Alembic Pharma shares jump 5% on final USFDA nod to Seizure treatment drug

Leave a ReplyCancel Reply

SEBI bans Gretex Corp for taking new merchant banking assignments for 21 days

Stocks to Watch: ITC, RIL, Swiggy, NTPC, and more

Meta’s $25 billion bond issue draws record $125 billion investor demand

Apple’s $4 trillion valuation on test as investors await iPhone-driven earnings boost

Macrotech Developers Q2 results: Profit jumps 87%, co on track to meet FY pre-sales goal of ₹21,000 crore